Teva Pharmaceutical Industries Limited
TEVA
Rank in Stocks
#13417
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Share Price
$40.38
Market Cap
$470.55M
Change (1 day)
-2.96%
Change (1 year)
101.80%
Country
IL
Trade Teva Pharmaceutical Industries Limited (TEVA)
Category
Healthcare
Stock price history for Teva Pharmaceutical Industries Limited (TEVA)
Highest end of day price: $36.76 on 2026-09-01
Lowest end of day price: $54.24 on 2010-06-01
Lowest end of day price: $54.24 on 2010-06-01
Stock price history of Teva Pharmaceutical Industries Limited from 2010 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 4.09% |
| 2025 | 49.61% |
| 2024 | 108.53% |
| 2023 | 2.76% |
| 2022 | 4.63% |
| 2021 | -17.41% |
| 2020 | -2.00% |
| 2019 | -49.57% |
| 2018 | 28.30% |
| 2017 | -68.90% |
| 2016 | -15.96% |
| 2015 | 6.30% |
| 2014 | 41.99% |
| 2013 | -0.79% |
| 2012 | 4.84% |
| 2011 | -27.88% |
| 2010 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
